(168 days)
Not Found
No
The device description focuses on mechanical components and their function in creating a pathway. There is no mention of software, algorithms, or data processing that would indicate the use of AI/ML. The performance studies listed are standard tests for mechanical and material properties of medical devices.
No.
The device is an access set used to create a pathway for the delivery of an endoprosthetic; it does not directly treat a disease or condition.
No
The device is described as an access set used to create a pathway for delivering an endoprosthetic, making it an interventional device. While the intended use mentions "diagnostic and interventional procedures," the device description solely focuses on its role in creating access for interventional procedures, specifically shunt placement. It does not perform any diagnostic function itself.
No
The device description clearly outlines multiple physical components (sheaths, dilators, catheters, stylets, needles, cannulas, handles) and performance testing related to physical properties (tensile strength, torque strength, leakage, corrosion, burst pressure, flow rate, fracture resistance), indicating it is a hardware medical device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "for transjugular liver access in diagnostic and interventional procedures." This describes a surgical or interventional tool used to create a pathway within the body.
- Device Description: The description details components like sheaths, dilators, catheters, stylets, and needles. These are all instruments used for accessing and manipulating anatomical structures within the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening. IVDs typically involve reagents, calibrators, controls, and instruments for analyzing biological samples.
The Scorpion Portal Vein Access Sets are clearly designed for direct use within the patient's body to facilitate a medical procedure, not for testing samples outside the body.
N/A
Intended Use / Indications for Use
The Scorpion Portal Vein Access Sets are intended for transjugular liver access in diagnostic and interventional procedures.
Product codes
DYB
Device Description
The Scorpion Portal Vein Access Sets have two models. One model has a Stylet as the puncture tool and the other model has a 17ga Needle as the puncture tool. The Scorpion Stylet Portal Vein Access Set contains a 10F Introducer Sheath, a 10F Dilator, a 5F MPA catheter, a 14ga Stiffening Cannula, a 0.040" Nitinol Stylet with a 5Fr PEEK Catheter, and a 7F Cannula Sheath. The 14ga stiffening cannula with cannula sheath has a directional handle that indicates the direction of the curve. The 10F Introducer Sheath hemostatic valve is designed to be compatible with up to 13F (4.3mm/0.171") sleeve. These components are used to create a pathway through the liver parenchyma through which an endoprosthetic can be delivered. The Scorpion Stylet Portal Vein Access Set is used to gain access to the hepatic vein and guide a sharp puncture tool (0.040" Stylet) through the parenchyma. The puncture tool (Stylet) is used to make a pathway from the hepatic vein to the portal vein, and then the pathway is dilated to provide access for a larger sheath. The shunt is inserted through the sheath and deployed through the pathway. Then, all of the Scorpion Stylet Portal Vein Access Set components are removed.
The Scorpion Needle Portal Vein Access Set contains a 10F Introducer Sheath, a 10F Dilator, a 5F MPA Catheter, a 13ga Scorpion Stiffening Cannula, 17ga Nitinol Needle, a 6.2F PEEK Catheter, and 8F Sheath Introducer. The 13ga stiffening cannula with cannula sheath has a directional handle that indicates the direction of the curve. The 17ga Nitinol Needle has a directional handle that indicates the direction of the 10F Introducer Sheath hemostatic valve is designed to be compatible with up to 13F (4.3mm/0.171") sleeve. These components are used to create a pathway through the liver parenchyma through which an endoprosthetic can be delivered. The Scorpion Needle Portal Vein Access Set is used to gain access to the hepatic vein and guide a sharp puncture tool (17ga Needle) through the parenchyma. The puncture tool (Needle) is used to make a pathway from the hepatic vein to the portal vein, and then the pathway is dilated to provide access for a larger sheath. The shunt is inserted through the sheath and deployed through the pathway. Then, all of the Scorpion Needle Portal Vein Access Set components are removed.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Liver, hepatic vein, portal vein
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
No performance standards have been established under section 514, performance standards, of the Food, Drug and Cosmetic Act for these devices. A series of testing was conducted in accordance with protocols based on requirements outlined in guidances and industry standards and the below were shown to meet the acceptance criteria that were determined to demonstrate substantial equivalence.
Performance Testing, including:
- Dimensional and Functional Fit
- Surface Inspection
- Component Compatibility
- Tensile Strength
- Torque Strength Test
- Liquid Leakage
- Air Leakage
- Corrosion Resistance
- Simulative Use
- Radiopacity
- Echogenicity
- Luer Connector Functional Testing
- Burst Pressure
- Flow Rate
- Resistance to Fracture Testing
Biocompatibility Testing, including:
- Cytotoxicity (ISO 10993-5)
- Sensitization (ISO 10993-10)
- Intracutaneous Irritation (ISO 10993-10)
- Acute Systemic Toxicity (ISO 10993-11)
- Material Mediated Pyrogen (ISO 10993-11)
- Hemocompatibility (ISO 10993-4)
- ASTM Hemolysis Direct and Indirect Contact
- Complement Activation, SC5b-9
- Thrombogenicity
- Platelet and Leucocyte Counts
- Partial Thromboplastin Time (PTT)
Key results: The results of all testing demonstrate that the Scorpion Portal Vein Access Set are substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1340 Catheter introducer.
(a)
Identification. A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
January 15, 2021
Argon Medical Devices, Inc. Amy Clendening-Wheeler Regulatory Affairs Manager 1445 Flat Creek Road Athens. Texas 75751
Re: K202141
Trade/Device Name: Scorpion Stylet Portal Vein Access Set, Scorpion Needle Portal Vein Access Set Regulation Number: 21 CFR 870.1340 Regulation Name: Catheter introducer Regulatory Class: Class II Product Code: DYB Dated: December 18, 2020 Received: December 21, 2020
Dear Amy Clendening-Wheeler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
1
devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
for
Misti Malone Assistant Director DHT2C: Division of Coronary and Peripheral Intervention Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202141
Device Name
Scorpion Stylet Portal Vein Access Set and Scorpion Needle Portal Vein Access Set
Indications for Use (Describe)
The Scorpion Portal Vein Access Sets are intended for transjugular liver access in diagnostic and interventional procedures.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
| Date Prepared: | December 30, 2020 |
|---|---|
| Company: | Argon Medical Devices, Inc. |
| 1445 Flat Creek Road | |
| Athens, Texas 75751 USA | |
| Facility Registration number: 1625425 | |
| Contact: | Amy Clendening-Wheeler |
| Regulatory Affairs Manager | |
| Phone: 469-731-1413 | |
| Fax: 469-731-1480 | |
| Email: amy.wheeler@argonmedical.com | |
| Device Trade | |
| Name: | Scorpion™ Portal Vein Access Set |
| Device | |
| Common | |
| Name: | Catheter Introducer |
| Device | |
| Classification: | Introducer, Catheter |
| Product code, DYB | |
| 21 CFR 870.1340 | |
| Class II | |
| Review Panel: Cardiovascular Devices | |
| Predicate | |
| Device(s): | Primary: K171820 Transjugular Liver Access Sets / Cook Incorporated |
| Description of | |
| the | |
| Device: | The Scorpion Portal Vein Access Sets have two models. One model has a Stylet as the |
| puncture tool and the other model has a 17ga Needle as the puncture tool. | |
| The Scorpion Stylet Portal Vein Access Set contains a 10F Introducer Sheath, a 10F | |
| Dilator, a 5F MPA catheter, a 14ga Stiffening Cannula, a 0.040" Nitinol Stylet with a 5Fr | |
| PEEK Catheter, and a 7F Cannula Sheath. The 14ga stiffening cannula with cannula | |
| sheath has a directional handle that indicates the direction of the curve. The 10F | |
| Introducer Sheath hemostatic valve is designed to be compatible with up to 13F | |
| (4.3mm/0.171") sleeve. These components are used to create a pathway through the | |
| liver parenchyma through which an endoprosthetic can be delivered. The Scorpion | |
| Stylet Portal Vein Access Set is used to gain access to the hepatic vein and guide a sharp | |
| puncture tool (0.040" Stylet) through the parenchyma. The puncture tool (Stylet) is used | |
| Indication for | |
| Use: | The Scorpion Portal Vein Access Sets are intended for transjugular liver access in |
| diagnostic and interventional procedures. | |
| Technological | |
| Characteristics: | A comparison of the technological characteristics of the subject device and the predicate |
| devices shows the Scorpion Portal Vein Access Set to be substantially equivalent to the | |
| current marketed predicate devices. | |
| Equivalence is based upon the product performance, design and intended use. The | |
| Scorpion Portal Vein Access Set and the predicate devices have similar materials of | |
| construction, dimensional specifications, designs and sterilization process. | |
| Performance | |
| Tests | |
| (Non-Clinical): | No performance standards have been established under section 514, performance |
| standards, of the Food, Drug and Cosmetic Act for | |
| these devices. A series of testing was conducted in accordance with | |
| protocols based on requirements outlined in guidances and industry | |
| standards and the below were shown to meet the acceptance criteria that were | |
| determined to demonstrate substantial equivalence. |
4
to make a pathway from the hepatic vein to the portal vein, and then the pathway is dilated to provide access for a larger sheath. The shunt is inserted through the sheath and deployed through the pathway. Then, all of the Scorpion Stylet Portal Vein Access Set components are removed.
The Scorpion Needle Portal Vein Access Set contains a 10F Introducer Sheath, a 10F Dilator, a 5F MPA Catheter, a 13ga Scorpion Stiffening Cannula, 17ga Nitinol Needle, a 6.2F PEEK Catheter, and 8F Sheath Introducer. The 13ga stiffening cannula with cannula sheath has a directional handle that indicates the direction of the curve. The 17ga Nitinol Needle has a directional handle that indicates the direction of the 10F Introducer Sheath hemostatic valve is designed to be compatible with up to 13F (4.3mm/0.171″) sleeve. These components are used to create a pathway through the liver parenchyma through which an endoprosthetic can be delivered. The Scorpion Needle Portal Vein Access Set is used to gain access to the hepatic vein and guide a sharp puncture tool (17ga Needle) through the parenchyma. The puncture tool (Needle) is used to make a pathway from the hepatic vein to the portal vein, and then the pathway is dilated to provide access for a larger sheath. The shunt is inserted through the sheath and deployed through the pathway. Then, all of the Scorpion Needle Portal Vein Access Set components are removed.
A Portal Vein Access Set is typically in use in procedures up to 4 hours.
5
The following tests were performed under the specified testing parameters to support the Scorpion Portal Vein Access Set substantial equivalence.
Performance Testing, including:
- Dimensional and Functional Fit ●
- Surface Inspection
- Component Compatibility ●
- Tensile Strength
- Torque Strength Test
- Liquid Leakage
- Air Leakage
- Corrosion Resistance
- Simulative Use
- Radiopacity
- Echogenicity
- Luer Connector Functional Testing ●
- Burst Pressure
- Flow Rate
- Resistance to Fracture Testing
Biocompatibility Testing, including:
- Cytotoxicity (ISO 10993-5) .
- Sensitization (ISO 10993-10) ●
- Intracutaneous Irritation (ISO 10993-10) .
- · Acute Systemic Toxicity (ISO 10993-11)
- Material Mediated Pyrogen (ISO 10993-11) .
- Hemocompatibility (ISO 10993-4) .
- ASTM Hemolysis Direct and Indirect Contact O
- Complement Activation, SC5b-9 O
- Thrombogenicity O
- Platelet and Leucocyte Counts O
- Partial Thromboplastin Time (PTT) O
Substantial Based on the Indication for Use, design, and safety and performance testing, the Equivalence: Scorpion Portal Vein Access Set meets the requirements for its intended use and is substantially equivalent to the predicate devices.
Substantial Equivalence Table
| SUBJECT DEVICE | PREDICATE DEVICE | |
|---|---|---|
| SCORPION | Transjugular Liver Access Sets | |
| (Rosch-Uchida and Ring) K171820 | ||
| Manufacturer | Argon Medical Devices, Inc. | Cook Incorporated |
| 510(k) | K202141 | K171820 |
6
| Class | II | SAME |
|---|---|---|
| Classification Name | Catheter Introducer | SAME |
| Regulation | 21 CFR 870.1340 | SAME |
| Product Code | DYB | SAME |
| Indication for Use | The Scorpion Portal Vein Access Set | |
| is intended for transjugular liver | ||
| access during diagnostic and | ||
| interventional procedures. | SAME | |
| Principle of Operation | Access to the jugular vein using | |
| standard access techniques. The | ||
| Introducer sheath and dilator are | ||
| inserted over the guidewire, | ||
| advanced, and positioned in the | ||
| hepatic vein and the dilator is | ||
| removed. The stiffening cannula and | ||
| cannula sheath, followed by the | ||
| puncturing tool and guide catheter, | ||
| are inserted into | ||
| the introducer sheath and the | ||
| puncturing tool is used to puncture | ||
| the hepatic vein, liver parenchyma | ||
| and access the portal vein. | SAME | |
| (In the case of the Ring set, the | ||
| puncturing tool and guide catheter | ||
| are inserted without use of a | ||
| stiffening cannula and cannula | ||
| sheath) | ||
| Contraindication | None Known | None Known |
| Single Use | YES | SAME |
| Device Description | Each Portal Vein Access Set contains | |
| a 10F wall-reinforced Introducer | ||
| Sheath with radiopaque tip, a 10F | ||
| Dilator, a 5F MPA catheter, a | ||
| puncturing tool that comes in the | ||
| following variations: 0.040" Stylet | ||
| with a 5Fr Stylet Catheter (separated | ||
| with a removable spacer clip) and a | ||
| 14ga Stiffening Cannula with a 7F | ||
| Cannula Sheath or 17ga Needle/6.2Fr | ||
| Catheter (separated with a | ||
| removable spacer clip) and a 13ga | ||
| Stiffening Cannula with an 8F | ||
| Cannula Sheath. The stiffening | ||
| cannulas and the stylet/needle | ||
| puncturing tools have curved distal | The Transjugular Liver Access Sets | |
| are comprised of various | ||
| components that facilitate | ||
| transjugular access to the liver for | ||
| the purpose of performing | ||
| interventional procedures. The sets | ||
| are grouped into two basic types: | ||
| the Ring Transjugular Intrahepatic | ||
| Access Set and the Rösch- Uchida | ||
| Transjugular Liver Access Set. Each | ||
| set includes core components | ||
| comprised of an introducer sheath | ||
| and dilator. The Ring Transjugular | ||
| Intrahepatic Access Set includes a | ||
| 16ga stainless steel needle with 9F | ||
| or 10F guiding catheter. The Rösch- | ||
| Uchida Transjugular Liver Access | ||
| Set includes a 14ga stainless steel | ||
| stiffening cannula with 10F catheter | ||
| but taper down to a 10F inner | ||
| diameter. | these sets are a Check-Flo | |
| Introducer Set, selective | ||
| catheters, and wire guides. | ||
| Introducer Set | ||
| Sheath Materials | Pebax or PTFE Inner Layer | |
| Stainless Steel Coil | ||
| Pebax Outer Layer | PTFE liner | |
| Stainless Steel Coil | ||
| Nylon Jacket | ||
| Sheath Marker Band | Pebax with 80% Tungsten black | |
| Pebax | Platinum/Iridium | |
| Sheath hub material | Polycarbonate (Makrolon) | Nylon |
| Sheath Inner Diameter | ||
| (Fr) | 10 | 9 or 10, 10 |
| Sheath Length (cm) | 42 | 38.5, 40 |
| Dilator | ||
| Outer diameter (F) | 10 | 9 or 10 (Rosch-Uchida), 10 (Ring) |
| Material | HDPE w/ Barium Sulfate | Polyethylene |
| Hub material | HDPE | HDPE |
| Length (cm) | 49 | 40, 51 |
| Dilator Endhole Size | ||
| (in) | .041 | 0.035, 0.038 |
| Catheter (MPA/MPB) | ||
| Outer diameter (F) | 5 | 5 |
| Length (cm) | 80 | 80 |
| Endhole size (in.) | .041 | 0.035 |
| Shaft materials | Nylon, Barium Sulfate, stainless steel | Teflon, Nylon |
| Tip material | Pebax, Bismute subcarbonate, | |
| Titanium dioxide | N/A | |
| Hub material | Polycarbonate | Polycarbonate |
| Puncturing Tool | ||
| Assembly | Stylet Set: | |
| 14ga Stiffening Cannula -Stainless | ||
| steel | ||
| 7F Cannula Sheath - HDPE | ||
| 0.040" x 73 cm Nitinol Stylet | ||
| reinforced with stainless steel | ||
| hypotube with a 5Fr Stylet PEEK | ||
| Catheter | ||
| HDPE Spacer clip | ||
| OR | ||
| Needle Set: | ||
| 13ga Stiffening Cannula- Stainless | ||
| steel | ||
| 8F Cannula Sheath - HDPE | ||
| 17ga x 73 cm Stainless Steel / | ||
| Nitinol composite Needle | ||
| 6.2F x 64 cm PEEK Catheter | ||
| HDPE Spacer clip | Rosch-Uchida Set (Stylet and | |
| catheter assembly) | ||
| 14ga Stiffening Access Cannula- | ||
| Stainless Steel | ||
| 10F Teflon Catheter | ||
| 0.038" Stainless Steel Needle | ||
| Stylet x 62.5cm with 5.2F Teflon | ||
| Catheter | ||
| OR | ||
| Ring Set (Colapinto Needle and | ||
| catheter assembly) | ||
| 16ga Stainless Steel Needle | ||
| 9F or 10F x 45.5 cm Teflon Catheter | ||
| Puncturing Tool | ||
| Catheter, composition | PEEK | Teflon/nylon |
| Bench Testing | ||
| Performance Testing | • Radiopacity | |
| • Echogenicity | ||
| • Corrosion Resistance | ||
| • Dimensional & Functional Fit | ||
| • Tensile Strength | ||
| • Torque Strength Test | ||
| • Liquid Leakage | ||
| • Air Leakage | ||
| • Burst Pressure | ||
| • Flow Rate | ||
| • Simulative Use - performance testing including dimensional, surface and compatibility of components | ||
| • Luer Functional Testing | ||
| • Shipping Test | ||
| • Resistance to Fracture Testing | • Radiopacity | |
| • Corrosion Resistance | ||
| • Tensile Strength | ||
| • Torque Strength Test | ||
| • Liquid leakage | ||
| • Air Leakage | ||
| • Burst Pressure | ||
| • Flexibility & Fracture | ||
| • Simulative Use – performance testing including dimensional, surface and compatibility of components | ||
| Biological Comparison | • Cytotoxicity (ISO 10993-5) | |
| • Sensitization (ISO 10993-10) | ||
| • Intracutaneous Irritation (ISO 10993-10) | ||
| • Acute Systemic Toxicity (ISO 10993-11) | ||
| • Material Mediated Pyrogen (ISO 10993-11) | ||
| • Hemocompatibility (ISO10993-4) | ||
| o ASTM Hemolysis – Direct and Indirect Contact | ||
| o Complement Activation, SC5b-9 | ||
| o In Vivo Thrombogenicity | ||
| o Platelet and Leucocyte counts | ||
| o Partial Thromboplastin Time (PTT) | • Cytotoxicity (ISO 10993-5) | |
| • Sensitization (ISO 10993-10) | ||
| • Intracutaneous | ||
| Reactivity/Irritation (ISO 10993-10) | ||
| • Acute Systemic Toxicity (ISO 10993-11) | ||
| • Material Mediated Pyrogenicity | ||
| • Hemocompatibility (ISO10993-4) |
- Hemolysis Direct/Indirect
- Complement Activation (ISO Direct Contact)
-In Vivo Thrombogenicity |
| Packaging
Configuration | PETG Tray in a Tyvek/poly pouch | Individually pouched components |
| Sterilization | Minimum SAL 10-6
EtO | SAME |
| Intended Shelf Life | 3 years | SAME |
7
8